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The eagerness in finding the most effective probiotic strain has attracted many 
investigations. Bifidobacterium pseudocatenulatum G4, strain isolated from free-living 
infant was reported to have characteristics as probiotic candidate. Meanwhile, inulin is a 
known natural source of carbon that can act as a prebiotic substance. The consumption of 
probiotic, prebiotic, and its combination (synbiotic) was reported to have the ability to 
alter microbial composition in human gastrointestinal tract (GIT). In this study, the 
effects of B. pseudocatenulatum G4 (probiotic), inulin (prebiotic) and its combination 
(synbiotic) towards the human GIT microbial composition were evaluated in vitro. The 
effects of inulin incorporated in chocolate products as one of its ingredients were also 
tested. Real-time PCR assay with selected genus- and species-specific primers were used 
as a tool in identification and enumeration of selected bacterial strain in fermentation of 
mixture of bacteria from human faecal sample while dilution and plate count technique 
was used to enumerate the bacterial cell in fermentation of pure culture bacteria. The 
morphology of the tested Bifidobacterium strains was observed and the species was 
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confirmed by molecular method targeting 16S rRNA gene. In pure culture batch 
fermentation of tryptone peptone yeast (TPY) medium supplemented with 0.5% inulin, B. 
pseudocatenulatum G4 grew at the growth rate of 0.53 ± 0.06 log10 h-1 as compared to 
other Bifidobacterium strains namely B. breve ATCC 15700, B. longum BB536, and B. 
infantis ATCC 15697 which grew at 0.45 ± 0.04 log10 h-1, 0.31 ± 0.08 log10 h-1, and 0.72 
± 0.03 log10 h-1, respectively. The same amount of inulin was then introduced into dark- 
and milk chocolate and caused B. pseudocatenulatum G4, B. breve ATCC 15700, B. 
longum BB536, and B. infantis ATCC 15697 to grow at 0.54 ± 0.06, 0.44 ± 0.04, 0.36 ± 
0.05, 0.73 ± 0.02 log10 h-1 for dark chocolate and 0.57 ± 0.05, 0.46 ± 0.03, 0.41 ± 0.04, 
0.75 ± 0.01 log10 h-1 for milk chocolate respectively. Some of the chocolate ingredients 
had also influenced the growth of B. pseudocatenulatum G4. The addition of 0.5% of 
cocoa liquor in TPY medium caused B. pseudocatenulatum G4 to grow at 0.29 ± 0.03 
log10  h-1, and isomalt at 0.59 ± 0.05 log10 h-1 compared to TPY medium without any 
additional carbon source which grew at 0.19 ± 0.02 log10 h-1, while the addition of cocoa 
butter did not support the growth of B. pseudocatenulatum G4. In 24 hours batch 
fermentation of human faecal bacteria, B. pseudocatenulatum G4 (Probiotic) showed its 
probiotic effects by inhibiting the growth of Salmonella and Enterococcus faecalis. The 
addition of inulin (Prebiotic) selectively supported the growth of Bifidobacterium and 
Lactobacillus as well as inhibits the growth of Bacteroides, Salmonella, and E. faecalis. 
The synbiotic combination of B. pseudocatenulatum G4 and inulin (Synbiotic) showed a 
synergestic effect as they reduced the number of Bacteroides, Salmonella, and E. faecalis 
better than Probiotic or Prebiotic alone. Synbiotic chocolate preparations (DCsynbiotic 
and MCsynbiotic) showed better synergestic effect with B. pseudocatenulatum G4 
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compared to Synbiotic when Bifidobacterium increased at 1.64 log10 (DCsynbiotic) and 
1.67 log10 cells/ml (MCsynbiotic) from the initial counts. Lactobacillus also increased its 
cell number higher than Synbiotic treatment. Nevertheless, synbiotic chocolate 
preparations also gave a positive result towards the growth of potential pathogenic 
bacteria when compared to Synbiotic. However, the inhibition pattern still can be 
observed on Salmonella and E. faecalis when compared to glucose (control). The 
antimicrobial action was largely due to the pattern of lactic and acetic acid production in 
fermentation. Here, the synbiotic approach was more efficient than prebiotic or probiotic 
alone to modulate the human GIT microbial composition and B. pseudocatenulatum G4 
with inulin is a compatible synbiotic pair to perform the function. 
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Keinginan untuk mencari strain probiotik yang paling berkesan telah menarik minat 
banyak penyelidikan. Bifidobacterium pseudocatenulatum G4, strain yang dipencilkan 
dari najis bayi telah dilaporkan mempunyai ciri-ciri sebagai calon probiotik. Manakala 
inulin sedia kala diketahui sebagai sumber karbon yang boleh bertindak sebagai bahan 
prebiotik. Pengambilan produk probiotik, prebiotik dan kombinasinya (sinbiotik) telah 
dilaporkan mempunyai kebolehan untuk merubah komposisi mikroorganisma di dalam 
saluran usus manusia. Oleh itu, dalam kajian ini, kesan B. pseudocatenulatum G4  
(probiotik), inulin (prebiotik) dan kombinasinya (sinbiotik) terhadap komposisi 
mikroorganisma di dalam saluran usus manusia telah dinilai secara in vitro. Kesan inulin 
yang telah dicampurkan ke dalam produk coklat sebagai salah satu bahan ramuan dalam 
pembuatannya juga telah diuji. Reaksi rantaian polimerase-masa nyata (real-time PCR) 
bersama pemula (primer) spesifik kepada genus dan spesis bakteria terpilih  telah 
digunakan sebagai alat untuk mengenal pasti dan mengira jumlah bakteria terpilih dalam 
fermentasi bakteria campuran dari sampel najis manusia manakala teknik pencairan dan 
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pengiraan kultur dalam piring digunakan untuk mengira sel bakteria dalam fermentasi 
kultur bakteria tulen. Morfologi kesemua strain bifidobacteria yang dikaji telah 
diperhatikan dan pengesahan di peringkat spesis pula dilakukan menggunakan teknik 
molekular yang mensasarkan gen 16S rRNA. Dalam fermentasi sesekelompok kultur 
tulen media TPY yang dibekalkan dengan 0.5% inulin, kadar pertumbuhan B. 
psuedocatenulatum G4 adalah pada 0.53 ± 0.06 log10 jam-1. Dalam perbandingan bersama 
strain bifidobacteria yang lain, B. breve ATCC 15700, B. longum BB536, dan B. infantis 
ATCC 15697, masing-masing tumbuh pada 0.45 ± 0.04 log10 jam-1, 0.31  ± 0.08 log10 
jam-1, and 0.72 ± 0.03 log10 jam-1. Kemudian, jumlah inulin yang sama dimasukkan ke 
dalam coklat hitam dan coklat susu dan menyebabkan B. pseudocatenulatum G4, B. 
breve ATCC 15700, B. longum BB536, dan B. infantis ATCC 15697 masing-masing 
tumbuh pada kadar 0.54 ± 0.06, 0.44 ± 0.04, 0.36 ± 0.05, 0.73 ± 0.02 log10 jam-1 untuk 
coklat hitam dan 0.57 ± 0.05, 0.46 ± 0.03, 0.41 ± 0.04, 0.75 ± 0.01 log10 jam-1 untuk 
coklat susu. Sebahagian dari bahan-bahan dalam coklat juga mempengaruhi pertumbuhan 
B. pseudocatenulatum G4. Penambahan likur koko dan isomalt dalam media TPY (0.5%) 
menjadikan B. pseudocatenulatum G4 membiak, masing-masing pada kadar 0.29 ± 0.03 
log10 jam-1, dan 0.59 ± 0.05 log10 jam-1 berbandingkan dengan media TPY tanpa apa-apa 
sumber karbon yang hanya menunjukkan B. pseudocatenulatum G4 membiak pada kadar 
0.19 ± 0.02 log10 jam-1, manakala penambahan mentega koko pula tidak menyokong 
pertumbuhan B. pseudocatenulatum G4. Dalam 24 jam fermentasi sesekelompok statik 
kultur campuran dari najis manusia, B. pseudocatenulatum G4 (Probiotic) telah 
menunjukkan kesan probiotiknya apabila merencat pertumbuhan Salmonella dan 
Enterococcus faecalis. Inulin juga menunjukkan kesan prebiotiknya apabila menyokong 
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pertumbuhan Bifidobacterium dan Lactobacillus secara selektif dan merencat 
pertumbuhan Bacteroides, Salmonella, and E. faecalis. Kombinasi sinbiotik oleh B. 
pseudocatenulatum G4 dan inulin menunjukkan kesan sinergistik apabila menurunkan 
jumlah bilangan Bacteroiodes, Salmonella and E. faecalis lebih baik dari apa yang 
dilakukan oleh sediaan Probiotic dan sediaan Prebiotic sahaja. Sediaan sinbiotik coklat 
(DCsynbiotik dan MCsynbiotic) juga menunjukkan kesan sinergistik yang lebih baik 
bersama B. pseudocatenulatum G4 apabila masing-masing meningkatkan bilangan 
Bifidobacterium sebanyak 1.64 log10 and 1.67 log10 sel/ml daripada kiraan permulaan. 
Peningkatan sel Lactobacillus juga lebih tinggi jika dibandingkan dengan sediaan 
Synbiotic. Selain daripada itu, persediaan sinbiotik coklat juga memberi keputusan yang 
positif terhadap pertumbuhan bakteria patogen apabila dibandingkan dengan sediaan 
Synbiotic. Walaupun begitu, corak perencatan masih lagi boleh diperhatikan ke atas 
Salmonella dan E. faecalis apabila dibandingkan dengan glukos (kawalan). Kesan 
antimikrob yang ditunjukkan dipengaruhi besar oleh corak penghasilan asid laktik dan 
asid asetik dalam fermentasi. Disini, pendekatan sinbiotik adalah lebih berkesan daripada 
prebiotik dan probiotik bersendirian dalam mengubahsuai komposisi mikroorganisma di 
dalam saluran usus manusia dan B. pseudocatenulatum G4 bersama inulin adalah 
pasangan sinbiotik yang sesuai untuk melakukan tugas ini.  
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CHAPTER 1 
 
INTRODUCTION 
 
The awareness on keeping good gastrointestinal tract (GIT) health among the public 
has risen nowadays. Inflammatory bowel disease (IBS), irritable bowel syndrome 
(IBS), Crohn’s disease, ulcerative colitis and Celiac disease are the common problem 
in gut due to unbalance of bacteria in GIT (Bradesi et al. 2003; Asakura et al. 2008; 
Collado et al. 2008).  Many factors affect the population of intestinal bacteria 
including diet, age, sex, use of drugs, surgery, and some diseases. Researches showed 
that maintaining a proper balance of bacteria in GIT is the key to good gut health 
(Gorbach 2000) and one of the ways to achieve it is by consuming probiotics and 
prebiotics. 
 
Probiotics and prebiotics are already a reputable sector in the health food market of 
developed countries. Probiotic dairy products were reported as one of the most 
developed and well-liked functional food products in European market (Shortt et al. 
2004). The  market is currently estimated to be worth more than USD 2 billion per 
annum (Saxelin 2008). In the USA, the annual market value of functional foods is 
estimated to be around USD80 billion in 2000. An estimated USD 1.86 billion is 
contributed by probiotics, and probiotic related products. The value is expected to 
grow to USD3.5 billion by 2007 (Sanders 1998). In Japan, the market size for 
probiotics and other dietary supplement segments, dominated (80%) the Foods for 
Special Health Use (FOSHU) category. The FOSHU market is estimated to worth  
more than USD 10 billion, annually (Amagase 2008). Meanwhile, in Malaysia, 
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probiotics and prebiotics are an emerging health food concept. Probiotic and prebiotic 
food products have a huge potential in the functional food market in Malaysia. Hence, 
special attention is required to develop the sector to be market driven and most 
important is to use locally manufactured products and expertise in order to participate 
and compete in the main stream of the field. 
 
The concept of ingesting live microorganisms for therapeutic and prophylactic 
purposes can be traced back to the beginning of the 20th century (Metchnikoff 1910). 
Ever since such discovery had been made, there has been rapid growth in research 
regarding the use of live bacterial cells to benefit humankind. Probiotic organisms 
influence the physiological and pathological process of the host by modifying the 
intestinal microbiota, thereby affecting human health (Erickson and Hubbard 2000).  
They have been used in the prevention and treatment of many GIT disorders, such as 
inflammatory bowel disease, antibiotic-related diarrhea, and post-resection disorders 
such as pouchitis (Gorbach 2000). Most of the applied probiotic microorganisms are 
of human origin and are largely represented by Bifidobacterium and Lactobacillus 
species in the commercial. For the past several years, research in our laboratory has 
focused on Bifidobacterium strain that shows the most probiotic characteristics. 
Bifidobacterium pseudocatenulatum G4 was isolated from free-living breast-fed 
infant by Yazid et al. (1999a) and has shown some characteristics as a probiotic 
candidate.  
 
Prebiotics is defined as non digestible food ingredient that beneficially affects the host 
by selectively stimulating the growth and/or activity of one or a limited number of 
bacteria in the colon and thus improve host health (Gibson and Roberfroid 1995). It is 
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a recent novel food concept that includes food ingredients that are not digested in the 
human upper intestinal tract and commonly used as a food additive (fiber), fat 
replacer, sugar substitute, or emulsifier. Dietary modulation of the gut microflora by 
prebiotics is designed to improve human health by reducing disease risk through the 
large intestinal surface with various physiological process and stimulating the 
numbers and/or activities of the bifidobacteria and lactobacilli (Manning and Gibson 
2004). Prebiotics for which sufficient data are available for their classification as 
functional food ingredients are the inulin-type fructans, which include native inulin, 
enzymatically hydrolysed inulin or oligofructose, and synthetic fructo-
oligosaccharides (FOSs) (Roberfroid and Delzenne 1998; Roberfroid et al. 1998). 
 
Inulin is a plant-derived carbohydrate with the benefits of soluble dietary fiber 
(Schneeman 1999). It was reported to be fermented by resident bacterial groups such 
as bifidobacteria once reaches the colon intact (Roberfroid et al. 1998). In addition, 
the bifidogenic effect of inulin has been well proven (Gibson and Roberfroid 1995; 
Kolida and Gibson 2007).  
 
Prebiotics are consumed by human generally in the form of ingredients in food 
products. Many food companies especially companies that produce dairy products 
take a prospect in developing a new product that contains prebiotic substances for the 
health claim. Inulin and fructo-oligosaccharides (FOS) have been studied in terms of 
their prebiotic activity in many studies. However, when it comes to its role as a food 
ingredient, only few tests took place. Most studies of prebiotics have involved the 
consumption of inulin- or oligosaccharide-containing powders, which may not be 
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relevant to everyday life because the substrates, for commercial use, would be 
incorporated into a food product (Tannock et al. 2004).  
 
Probiotics, when applied in conjugation with prebiotics give rise to another possibility 
in microflora management technique known as synbiotics (Gibson and Roberfroid 
1995). This combination could confer greater advantages to the host owing to greater 
survivality of probiotic candidate due to availability of substrate for its fermentation. 
Probiotics, prebiotics and synbiotics can be classified as health-enhancing and health-
promoting functional food concepts. However, only a few combinations of 
pre/probiotics have been evaluated as synbiotics, with only a limited number 
determining effects on the human faecal microbiota using reliable molecular 
techniques (Saulnier 2007) and to date, finding the novel probiotic strain and the best 
synbiotic preparation still remains a challenge (Liong and Shah 2008). Thus, this 
study was conducted to elucidate the effect of synbiotic preparation of our own 
probiotic candidate, B. pseudocatenulatum G4 with inulin towards the bacterial 
composition in human GIT using real-time PCR assays. Here, we describe the first 
stages in the development of a synbiotic, by first determine the ability of probiotic 
strain of interest to metabolize prebiotic substance of interest, then by evaluating their 
effect on the faecal microbiota in vitro, to assess whether the synbiotic can have a 
superior functionality as compared with its probiotic/prebiotic components. Synbiotic 
function was also tested in food products to see whether the functionality of synbiotic 
was affected or not by the food itself. This general objective meets the specific 
objectives as listed below: 
 
